Diabetes Care, Vol 22, Issue 11 1827-1831, Copyright © 1999 by American Diabetes Association

ARTICLES

Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients

AM Norhammar, L Ryden and K Malmberg
Department of Cardiology, Karolinska Hospital, Stockholm, Sweden.

OBJECTIVE: To investigate whether a relationship exists between admission plasma glucose level and long-term outcome in nondiabetic patients after an acute myocardial infarction. RESEARCH DESIGN AND METHODS: This was a retrospective study with prospective follow-up of 197 consecutive nondiabetic patients with acute myocardial infarction followed for 1.5-2.5 years at the Department of Cardiology at Karolinska Hospital. RESULTS: The mean admission plasma glucose level was 8.15 +/- 3.0 mmol/l. During follow-up, 60 (30%) patients died, 20 (10%) were rehospitalized for heart failure, 12 (6%) were rehospitalized for nonfatal reinfarction, and 79 (40%) had at least one of these events. In univariate analysis, admission plasma glucose level was significantly higher in patients who had any of the predefined events than in those without these events. In a multivariate Cox proportional hazard regression model that allowed for confounding baseline predictors, admission plasma glucose level was an independent predictor of nonfatal reinfarction (P = 0.006), hospitalization for heart failure (P = 0.0034), and a major cardiovascular event (P = 0.0042) and was of borderline significance for death during long-term follow-up (P = 0.09). CONCLUSIONS: Admission plasma glucose level in nondiabetic patients with acute myocardial infarction seems to be an independent predictor of long-term outcome. This indicates that an elevated admission plasma glucose level not only reflects acute stress, but also may be a marker of disturbed glucose metabolism that worsens the prognosis and requires intervention.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Undas, I. Wiek, E. Stepien, K. Zmudka, and W. Tracz Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome Diabetes Care, August 1, 2008; 31(8): 1590 - 1595. [Abstract] [Full Text] [PDF]

				U. Holzinger, M. Feldbacher, A. Bachlechner, R. Kitzberger, V. Fuhrmann, and C. Madl Improvement of Glucose Control in the Intensive Care Unit: An Interdisciplinary Collaboration Study Am. J. Crit. Care., March 1, 2008; 17(2): 150 - 156. [Abstract] [Full Text] [PDF]

				C Weston, L Walker, J Birkhead, and National Audit of Myocardial Infarction Project, N Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome Heart, December 1, 2007; 93(12): 1542 - 1546. [Abstract] [Full Text] [PDF]

				K. Asadollahi, N. Beeching, and G. Gill Hyperglycaemia and mortality J R Soc Med, November 1, 2007; 100(11): 503 - 507. [Abstract] [Full Text] [PDF]

				K. Asadollahi, I.M. Hastings, N.J. Beeching, and G.V. Gill Laboratory risk factors for hospital mortality in acutely admitted patients QJM, August 1, 2007; 100(8): 501 - 507. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]

				J. B. Boord, M. Sharifi, R. A. Greevy, M. R. Griffin, V. K. Lee, T. A. Webb, M. E. May, L. R. Waitman, A. K. May, and R. A. Miller Computer-based Insulin Infusion Protocol Improves Glycemia Control over Manual Protocol J. Am. Med. Inform. Assoc., May 1, 2007; 14(3): 278 - 287. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]

				D.-Y. Hu, C.-Y. Pan, J.-M. Yu, and for the China Heart Survey Group The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey Eur. Heart J., November 1, 2006; 27(21): 2573 - 2579. [Abstract] [Full Text] [PDF]

				K. A. Wintergerst, B. Buckingham, L. Gandrud, B. J. Wong, S. Kache, and D. M. Wilson Association of Hypoglycemia, Hyperglycemia, and Glucose Variability With Morbidity and Death in the Pediatric Intensive Care Unit Pediatrics, July 1, 2006; 118(1): 173 - 179. [Abstract] [Full Text] [PDF]

				Z Kadri, N Danchin, L Vaur, Y Cottin, P Gueret, M Zeller, J-M Lablanche, D Blanchard, G Hanania, N Genes, et al. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study Heart, July 1, 2006; 92(7): 910 - 915. [Abstract] [Full Text] [PDF]

				A. Goyal, K. W. Mahaffey, J. Garg, J. C. Nicolau, J. S. Hochman, W. D. Weaver, P. Theroux, G. B.F. Oliveira, T. G. Todaro, C. F. Mojcik, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study Eur. Heart J., June 1, 2006; 27(11): 1289 - 1297. [Abstract] [Full Text] [PDF]

				N. W. Cheung, V. W. Wong, and M. McLean The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study: A randomized controlled trial of insulin infusion therapy for myocardial infarction Diabetes Care, April 1, 2006; 29(4): 765 - 770. [Abstract] [Full Text] [PDF]

				H. Ishii, S. Ichimiya, M. Kanashiro, T. Amano, T. Matsubara, and T. Murohara Effects of Intravenous Nicorandil Before Reperfusion for Acute Myocardial Infarction in Patients With Stress Hyperglycemia Diabetes Care, February 1, 2006; 29(2): 202 - 206. [Abstract] [Full Text] [PDF]

				A. X. Freire, L. Bridges, G. E. Umpierrez, D. Kuhl, and A. E. Kitabchi Admission Hyperglycemia and Other Risk Factors as Predictors of Hospital Mortality in a Medical ICU Population Chest, November 1, 2005; 128(5): 3109 - 3116. [Abstract] [Full Text] [PDF]

				R Otten, E Kline-Rogers, D J Meier, R Dumasia, J Fang, N May, Y Resin, D F Armstrong, F Saab, M Petrina, et al. Impact of pre-diabetic state on clinical outcomes in patients with acute coronary syndrome Heart, November 1, 2005; 91(11): 1466 - 1468. [Full Text] [PDF]

				A. Ramachandran, S. Chamukuttan, S. Immaneni, R. M. Shanmugam, N. Vishnu, V. Viswanathan, and T. Jaakko High Incidence of Glucose Intolerance in Asian-Indian Subjects With Acute Coronary Syndrome Diabetes Care, October 1, 2005; 28(10): 2492 - 2496. [Abstract] [Full Text] [PDF]

				R. Lattermann, G. Belohlavek, S. Wittmann, B. Fuchtmeier, and M. Gruber The Anticatabolic Effect of Neuraxial Blockade After Hip Surgery Anesth. Analg., October 1, 2005; 101(4): 1202 - 1208. [Abstract] [Full Text] [PDF]

				R. E. Anderson, K. Brismar, G. Barr, and T. Ivert Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 425 - 430. [Abstract] [Full Text] [PDF]

				A.-M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events Eur. Heart J., July 1, 2005; 26(13): 1255 - 1261. [Abstract] [Full Text] [PDF]

				T. M Conner, K. R Flesner-Gurley, and J. C Barner Hyperglycemia in the Hospital Setting: The Case for Improved Control Among Non-Diabetics Ann. Pharmacother., March 1, 2005; 39(3): 492 - 501. [Abstract] [Full Text] [PDF]

				O. Akca and R. Lenhardt Letter to the Editors: Isn't It the Time to Consider Blood Glucose Concentration as Part of the Severity Assessment of Critically Ill Patients? J Intensive Care Med, January 1, 2005; 20(1): 52 - 53. [PDF]

				K. M. Choi, K. W. Lee, S. G. Kim, N. H. Kim, C. G. Park, H. S. Seo, D. J. Oh, D. S. Choi, and S. H. Baik Inflammation, Insulin Resistance, and Glucose Intolerance in Acute Myocardial Infarction Patients without a Previous Diagnosis of Diabetes Mellitus J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 175 - 180. [Abstract] [Full Text] [PDF]

				M. Bartnik, K. Malmberg, A. Norhammar, A. Tenerz, J. Ohrvik, and L. Ryden Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction Eur. Heart J., November 2, 2004; 25(22): 1990 - 1997. [Abstract] [Full Text] [PDF]

				M. Bartnik, L. Ryden, R. Ferrari, K. Malmberg, K. Pyorala, M. Simoons, E. Standl, J. Soler-Soler, J. Ohrvik, and on behalf of the Euro Heart Survey Investigators The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart Eur. Heart J., November 1, 2004; 25(21): 1880 - 1890. [Abstract] [Full Text] [PDF]

				C. Kragelund, O. Snorgaard, L. Kober, B. Bengtsson, M. Ottesen, S. Hojberg, C. Olesen, J.-J. Kjaergaard, J. Carlsen, C. Torp-Petersen, et al. Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients Eur. Heart J., November 1, 2004; 25(21): 1891 - 1897. [Abstract] [Full Text] [PDF]

				I. Stranders, M. Diamant, R. E. van Gelder, H. J. Spruijt, J. W. R. Twisk, R. J. Heine, and F. C. Visser Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes Mellitus Arch Intern Med, May 10, 2004; 164(9): 982 - 988. [Abstract] [Full Text] [PDF]

				S. J. Finney, C. Zekveld, A. Elia, and T. W. Evans Glucose Control and Mortality in Critically Ill Patients JAMA, October 15, 2003; 290(15): 2041 - 2047. [Abstract] [Full Text] [PDF]

				A. Tenerz, A. Norhammar, A. Silveira, A. Hamsten, G. Nilsson, L. Ryden, and K. Malmberg Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes Diabetes Care, October 1, 2003; 26(10): 2770 - 2776. [Abstract] [Full Text] [PDF]

				H. B. van Wezel and S. W. M. d. Jong Clinical Use of Glucose-Insulin-Potassium in Cardiac Surgery andAcute Myocardial Infarction: An Overview Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 77 - 83. [PDF]

				G. E. Umpierrez and A. E. Kitabchi Authors' Response: Hyperglycemia--An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1402 - 1402. [Full Text]

				P. Dandona, A. Aljada, and A. Bandyopadhyay The Potential Therapeutic Role of Insulin in Acute Myocardial Infarction in Patients Admitted to Intensive Care and in Those With Unspecified Hyperglycemia Diabetes Care, February 1, 2003; 26(2): 516 - 519. [Full Text] [PDF]

				N. N. Wahab, E. A. Cowden, N. J. Pearce, M. J. Gardner, H. Merry, J. L. Cox, and ICONS Investigators Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1748 - 1754. [Abstract] [Full Text] [PDF]

				L. Ryden and K. Malmberg Who are the enemies? Diabetes mellitus -- a major risk factor for ischaemic myocardial injury: new directions in the management of acute coronary syndromes in the diabetic patient Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G21 - G25. [Abstract] [PDF]

				J Sala, R Masia, F-J Gonzalez de Molina, J M Fernandez-Real, M Gil, D Bosch, W Ricart, M Senti, and J Marrugat Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission J. Epidemiol. Community Health, September 1, 2002; 56(9): 707 - 712. [Abstract] [Full Text] [PDF]

				M. Sharma Extolling the Virtues of Euglycemia Clin. Diabetes, April 1, 2002; 20(2): 87 - 88. [Full Text] [PDF]

				G. E. Umpierrez, S. D. Isaacs, N. Bazargan, X. You, L. M. Thaler, and A. E. Kitabchi Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 978 - 982. [Abstract] [Full Text] [PDF]

				T. W. Evans Hemodynamic and Metabolic Therapy in Critically Ill Patients N. Engl. J. Med., November 8, 2001; 345(19): 1417 - 1418. [Full Text] [PDF]

				D. Zindrou, K. M. Taylor, and J. P. Bagger Admission Plasma Glucose: An independent risk factor in nondiabetic women after coronary artery bypass grafting Diabetes Care, September 1, 2001; 24(9): 1634 - 1639. [Abstract] [Full Text] [PDF]